Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis
- PMID: 15205330
- DOI: 10.1158/0008-5472.CAN-03-3235
Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis
Abstract
The "a disintegrin and metalloprotease" (ADAM) family contributes to regulation of the cell-cell and cell-matrix interactions that are critical determinants of malignancy. To determine the relationship between metastasis and ADAM proteins, we compared the mRNA levels of ADAM9, -10, -12, -15, and -17 in sublines of an EBC-1 lung cancer cell line that were highly metastatic to either brain or bone. ADAM9 mRNA levels were significantly higher in highly brain-metastatic sublines than in the parent or highly bone-metastatic sublines. To elucidate the role of ADAM9 in brain metastasis, we stably transfected A549 and EBC-1 cells with a full-length ADAM9 expression vector. Compared with mock-transfectants, ADAM9 overexpression resulted in increased invasive capacity in response to nerve growth factor, increased adhesion to brain tissue, and increased expression of integrin alpha 3 and beta 1 subunits. Administration of the anti-beta 1 monoclonal antibody attenuated this increase in invasive and adhesive activity. Intravenous administration of ADAM9-overexpressing A549 cells to mice resulted in micrometastatic foci in the brain and multiple metastatic colonies in the lungs. In contrast, administration of parent and mock-transfected A549 cells to mice resulted in lung tumors without brain metastasis. These results suggest that ADAM9 overexpression enhances cell adhesion and invasion of non-small cell lung cancer cells via modulation of other adhesion molecules and changes in sensitivity to growth factors, thereby promoting metastatic capacity to the brain.
Similar articles
-
c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties.Cancer Res. 1994 Jun 15;54(12):3260-6. Cancer Res. 1994. PMID: 7911396
-
A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions.Cancer Res. 2005 Jun 1;65(11):4728-38. doi: 10.1158/0008-5472.CAN-04-4449. Cancer Res. 2005. PMID: 15930291
-
Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells.Clin Cancer Res. 2005 Dec 1;11(23):8273-80. doi: 10.1158/1078-0432.CCR-05-0537. Clin Cancer Res. 2005. PMID: 16322285
-
Cell interactions in the metastatic process: some cell surface properties associated with successful blood-borne tumor spread.Soc Gen Physiol Ser. 1977;32:225-41. Soc Gen Physiol Ser. 1977. PMID: 333594 Review. No abstract available.
-
[Molecular and cell aspects of the cancer metastasis].Acta Cient Venez. 2001;52(4):304-12. Acta Cient Venez. 2001. PMID: 11915449 Review. Spanish.
Cited by
-
MiR-126 regulated breast cancer cell invasion by targeting ADAM9.Int J Clin Exp Pathol. 2015 Jun 1;8(6):6547-53. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26261534 Free PMC article.
-
RNAi-mediated ADAM9 gene silencing inhibits metastasis of adenoid cystic carcinoma cells.Tumour Biol. 2010 Jun;31(3):217-24. doi: 10.1007/s13277-010-0034-8. Epub 2010 Apr 27. Tumour Biol. 2010. PMID: 20422344
-
The ectodomain shedding of E-cadherin by ADAM15 supports ErbB receptor activation.J Biol Chem. 2008 Jun 27;283(26):18393-401. doi: 10.1074/jbc.M801329200. Epub 2008 Apr 22. J Biol Chem. 2008. PMID: 18434311 Free PMC article.
-
Brain metastasis in lung cancer: Building a molecular and systems-level understanding to improve outcomes.Int J Biochem Cell Biol. 2016 Sep;78:288-296. doi: 10.1016/j.biocel.2016.07.025. Epub 2016 Jul 27. Int J Biochem Cell Biol. 2016. PMID: 27474492 Free PMC article. Review.
-
ADAMs in cancer cell proliferation and progression.Cancer Sci. 2007 May;98(5):621-8. doi: 10.1111/j.1349-7006.2007.00434.x. Epub 2007 Mar 9. Cancer Sci. 2007. PMID: 17355265 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous